Form 8-K - Current report:
SEC Accession No. 0001641172-25-021006
Filing Date
2025-07-25
Accepted
2025-07-25 16:05:47
Documents
13
Period of Report
2025-07-21
Items
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 43169
  Complete submission text file 0001641172-25-021006.txt   252661

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE cing-20250721.xsd EX-101.SCH 3780
3 XBRL DEFINITION FILE cing-20250721_def.xml EX-101.DEF 26634
4 XBRL LABEL FILE cing-20250721_lab.xml EX-101.LAB 36717
5 XBRL PRESENTATION FILE cing-20250721_pre.xml EX-101.PRE 25258
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5722
Mailing Address 1901 W. 47TH PLACE KANSAS CITY KS 66205
Business Address 1901 W. 47TH PLACE KANSAS CITY KS 66205 (913) 942-2300
Cingulate Inc. (Filer) CIK: 0001862150 (see all company filings)

EIN.: 863825535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40874 | Film No.: 251151723
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)